Lindbrook Capital, LLC Repligen Corp Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Repligen Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 171 shares of RGEN stock, worth $24,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171

Previous 52 228.85%

Holding current value

$24,702

Previous $6,000 316.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$119.79 - $167.35 $14,255 - $19,914	119 Added 228.85%	171 $25,000
Q2 2024 Jul 31, 2024	SELL	$120.0 - $182.95 $8,160 - $12,440	-68 Reduced 56.67%	52 $6,000
Q1 2024 Apr 25, 2024	BUY	$170.78 - $208.42 $512 - $625	3 Added 2.56%	120 $22,000
Q4 2023 Jan 31, 2024	BUY	$114.17 - $185.35 $7,078 - $11,491	62 Added 112.73%	117 $21,000
Q3 2023 Oct 25, 2023	SELL	$138.78 - $176.51 $277 - $353	-2 Reduced 3.51%	55 $8,000
Q2 2023 Jul 28, 2023	SELL	$138.42 - $180.31 $415 - $540	-3 Reduced 5.0%	57 $8,000
Q1 2023 Apr 26, 2023	BUY	$154.26 - $198.1 $3,239 - $4,160	21 Added 53.85%	60 $10,000
Q4 2022 Jan 24, 2023	SELL	$162.42 - $220.56 $3,573 - $4,852	-22 Reduced 36.07%	39 $0
Q3 2022 Nov 10, 2022	BUY	$160.42 - $256.21 $4,652 - $7,430	29 Added 90.63%	61 $11,000
Q2 2022 Aug 01, 2022	SELL	$140.68 - $188.02 $6,049 - $8,084	-43 Reduced 57.33%	32 $5,000
Q1 2022 Apr 21, 2022	SELL	$161.19 - $257.96 $9,510 - $15,219	-59 Reduced 44.03%	75 $14,000
Q4 2021 Jan 18, 2022	BUY	$247.59 - $304.47 $4,951 - $6,089	20 Added 17.54%	134 $35,000
Q3 2021 Nov 05, 2021	BUY	$194.77 - $324.21 $194 - $324	1 Added 0.88%	114 $33,000
Q2 2021 Jul 27, 2021	SELL	$165.87 - $220.95 $995 - $1,325	-6 Reduced 5.04%	113 $23,000
Q1 2021 Apr 28, 2021	BUY	$180.37 - $226.26 $2,525 - $3,167	14 Added 13.33%	119 $23,000
Q4 2020 Jan 27, 2021	BUY	$148.08 - $206.57 $9,625 - $13,427	65 Added 162.5%	105 $20,000
Q3 2020 Nov 03, 2020	BUY	$122.51 - $158.27 $2,327 - $3,007	19 Added 90.48%	40 $6,000
Q4 2018 Feb 07, 2019	BUY	$48.26 - $68.88 $1,013 - $1,446	21 New	21 $1,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Repligen Corp Transaction History